Moore Capital Management »

BioMarin Pharmaceutical shares owned by Moore Capital Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2011-09-30 $3.3M 104k 31.87
2011-06-30 $5.4M 200k 27.21
2011-03-31 $3.5M 138k 25.13

More positions owned by Moore Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Spdr Ser Tr S&p Biotech (XBI)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Ally Financial (ALLY)
Allstate Corporation (ALL)
Spdr Ser Tr S&p Regl Bkg (KRE)
Vaneck Etf Trust Gold Miners Etf (GDX)
salesforce (CRM)
Progressive Corporation (PGR)
Vertiv Holdings Com Cl A (VRT)
Select Sector Spdr Tr Indl Call Option (XLI)

View all positions for Moore Capital Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical